Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers

Drug Metabolism and Disposition

Volumn 32, Issue 3, 2004, Pages 348-358

  Faucette, Stephanie R ^a   Wang, Hongbing ^a   Hamilton, Geraldine A ^a   Jolley, Summer L ^a   Gilbert, Darryl ^a   Lindley, Celeste ^a   Yan, Bingfang ^b   Negishi, Masahiko ^c   LeCluyse, Edward L ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CARBAMAZEPINE; CLOTRIMAZOLE; CYTOCHROME P450 2B6; CYTOCHROME P450 3A4; DEXAMETHASONE; HEXANOIC ACID; METHOTREXATE; PACLITAXEL; PHENOBARBITAL; PHENYTOIN; PREGNANE X RECEPTOR; PROBENECID; RIFAMPICIN; RITONAVIR; SULFADIMIDINE; SULFINPYRAZONE; TERT BUTYL ACETATE; TROLEANDOMYCIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONCENTRATION RESPONSE; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROXYLATION; LIVER CELL; LIVER CELL CULTURE; LIVER MICROSOME; MALE; PHARMACOKINETICS; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; STATISTICAL ANALYSIS; WESTERN BLOTTING;

ALGORITHMS; ARYL HYDROCARBON HYDROXYLASES; BLOTTING, WESTERN; CATALYSIS; CELL LINE; CELL SEPARATION; CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; ENZYME INDUCTION; GENES, REPORTER; HEPATOCYTES; HUMANS; LUCIFERASES; MICROSOMES, LIVER; OXIDOREDUCTASES, N-DEMETHYLATING; PLASMIDS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; TRANSFECTION;

EID: 0347689682     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.32.3.348     Document Type: Article

References (49)

1. Ariyoshi N, Miyazaki M, Toide K, Sawamura Y, and Kamataki T (2001) A single nucleotide polymorphism of CYP2B6 found in Japanese enhances catalytic activity by autoactivation. Biochem Biophys Res Commun 281:1256-1260.
2. Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, Sydow-Backman M, Ohlsson R, Postlind H, Blomquist P, and Berkenstam A (1998) Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci USA 95:12208-12213.
3. Blumberg B, Sabbagh W Jr, Juguilon H, Bolado J Jr, van Meter CM, Ong ES, and Evans RE (1998) SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev 12:3195-3205.
4. Brown SE, Guzelian CP, Schuetz E, Quattrochi LC, Kleinman HK, and Guzelian PS (1995) Critical role of extracellular matrix on induction by phenobarbital of cytochrome P450 2B1/2 in primary cultures of adult rat hepatocytes. Lab Investig 73:818-827.
5. Chang TKH, Yu L, Maurel P, and Waxman DJ (1997) Enhanced cyclophosphamide and ifosfamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines. Cancer Res 57:1946-1954.
6. Code EL, Crespi CL, Penman BW, Gonzalez FJ, Chang TKH, and Waxman DJ (1997) Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity and role in procarcinogen activation. Drug Metab Dispos 25:985-993.
7. Court MH, Duan SX, Hesse LM, Venkatakrishnan K, and Greenblatt DJ (2001) Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes. Anesthesiology 94:110-119.
8. Drocourt L, Pascussi J-M, Assenat E, Fabre J-M, Maurel P, and Vilarem M-J (2001) Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B and CYP2C in human hepatocytes. Drug Metab Dispos 29:1325-1331.
9. Du A-Y, Mutlib A, and Gan L (2000) A high throughput quantitative LC/MS assay for a marker metabolite of specific probe substrate (efavirenz) of human cytochrome P450 2B6 (Abstract 100). ISSX Proc 32:186.
10. Ducharme MP, Bernstein ML, Granvil CP, Gehrcke B, and Wainer IW (1997) Phenytoin-induced alteration in the N-dechloroethylation of ifosfamide stereoisomers. Cancer Chemother Pharmacol 40:531-533.
11. Ekins S, VandenBranden M, Ring BJ, Gillespie JS, Yang TJ, Gelboin HV, and Wrighton SA (1998) Further characterization of the expression in liver and catalytic activity of CYP2B6. J Pharmacol Exp Ther 286:1253-1259.
12. El-Sankary W, Bombail V, Gibson GG, and Plant N (2002) Glucocorticoid-mediated induction of CYP3A4 is decreased by disruption of a protein:DNA interaction distinct from the pregnane X receptor response element. Drug Metab Dispos 30:1029-1034.
13. Erickson DA, Mather G, Trager WF, Levy RH, and Keims J (1999) Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450. Drug Metab Dispos 27:1488-1495.
14. Faucette SR, Hawke RL, LeCluyse EL, Shord SS, Yan B, Laetham R, and Lindley CM (2000) Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity. Drug Metab Dispos 28:1222-1230.
15. Forman BM, Tzameli I, Choi H-S, Chen J, Simha D, Seol W, Evans RM, and Moore DD (1998) Androstane metabolites bind to and deactivate the nuclear receptor CAR-β. Nature (Lond) 395:612-615.
16. Gervot L, Rochat B, Gautier JC, Bohnenstengel F, Kroemer H, de Berardinis V, Martin H, Beaune P, and de Waziers I (1999) Human CYP2B6: expression, inducibility and catalytic activities. Pharmacogenetics 9:295-306.
17. Goodwin B, Moore LB, Stoltz CM, McKee DD, and Kliewer SA (2001) Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Mol Pharmacol 60:427-431.
18. Hamilton GA, Jolley SL, Gilbert D, Coon DJ, Barros S, and LeCluyse EL (2001) Regulation of cell morphology and cytochrome P450 expression in human hepatocytes by extracellular matrix and cell-cell interactions. Cell Tissue Res 306:85-99.
19. Hanna IH, Reed JR, Guengerich FP, and Hollenberg PF (2000) Expression of human cytochrome P450 2B6 in Escherichia coli: characterization of catalytic activity and expression levels in human liver. Arch Biochem Biophys 376:206-216.
20. Hesse LM, Venkatakrishnan K, Court MH, von Moltke LL, Duan SX, Shader RI, and Greenblatt DJ (2000) CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants. Drug Metab Dispos 28:1176-1183.
21. Hidestrand M, Oscarson M, Salonen JS, Nyman L, Pelkonen O, Turpeinen M, and Ingelman-Sundberg M (2001) CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes. Drug Metab Dispos 29:1480-1484.
22. Honkakoski P, Moore R, Washburn KA, and Negishi M (1998a) Activation by diverse xeno-chemicals of the 51-base pair phenobarbital-responsive enhancer module in the CYP2B10 gene. Mol Pharmacol 53:597-601.
23. Honkakoski P, Zelko I, Sueyoshi T, and Negishi M (1998b) The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol Cell Biol 18:5652-5658.
24. Jones SA, Moore LB, Shenk JL, Wisely GB, Hamilton GA, McKee DD, Tomkinson NCO, LeCluyse EL, Lambert MH, Wilson TM, et al. (2000) The pregnane X receptor, a promiscuous nuclear xenobiotic receptor that has diverged during evolution. Mol Endocrinol 14:27-39.
25. Kawamoto T, Sueyoshi T, Zelko I, Moore R, Washburn K, and Negishi M (1999) Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol Cell Biol 19:6318-6322.
26. Ketter TA, Jenkins JB, Schroeder DH, Pazzaglia PJ, Marangell LB, George MS, Callahan AM, Hinton ML, Chao J, and Post RM (1995) Carbamazepine but not valproate induces bupropion metabolism. J Clin Psychopharmacol 15:327-333.
27. Lang T, Klein K, Fischer J, Nussler AK, Neuhaus P, Hofmann U, Eichelbaum M, Schwab M, and Zanger UM (2001) Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics 11:399-415.
28. LeCluyse E, Madan A, Hamilton G, Carroll K, DeHaan R, and Parkinson A (2000) Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes. J Biochem Toxicol 14:177-188.
29. Lehmann JM, McKee DD, Watson MA, Wilson TM, Moore JT, and Kliewer SA (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Investig 102:1016-1023.
30. Luo G, Cunningham M, Sim S, Burn T, Lin J, Sinz M, Hamilton G, Rizzo C, Jolley S, Gilbert D, et al. (2002) CYP3A4 induction by drugs: correlation between a PXR reporter gene assay and CYP3A4 expression in human hepatocytes. Drug Metab Dispos 30:795-804.
31. Mäkinen J, Frank C, Jyrkkärinne J, Gynther J, Carlberg C, and Honkakoski P (2002) Modulation of mouse and human phenobarbital-responsive enhancer module by nuclear receptors. Mol Pharmacol 62:366-378.
32. Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Wilson TM, et al. (2000) Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275: 15122-15127.
33. Oakley RH, Sar M, and Cidlowski JA (1996) The human glucocorticoid receptor beta isoform. Expression, biochemical properties and putative function. J Biol Chem 271:9550-9559.
34. Pascussi J-M, Gerbal-Chaloin S, Fabre J-M, Maurel P, and Vilarem M-J (2000) Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Mol Pharmacol 58:1441-1450.
35. Pearce RE, McIntyre CJ, Madan A, Sanzgiri U, Draper AJ, Bullock PL, Cook DC, Burton LA, Latham J, Nevins C, and Parkinson A (1996) Effects of freezing, thawing and storing human liver microsomes on cytochrome P450 activity. Arch Biochem Biophys 331:145-169.
36. Ribera E, Pou L, Lopez RM, Crespo M, Falco V, Ocana I, Ruiz I, and Pahissa A (2001) Pharmacokinetic interaction between nevirapine and rifampicin in HIV-infected patients with tuberculosis. J Acquir Immune Defic Syndr 28;450-453.
37. Roy P, Yu LJ, Crespi CL, and Waxman DJ (1999) Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles. Drug Metab Dispos 27:655-666.
38. Sahi J, Hamilton G, Sinz M, Barros S, Huang S-M, Lesko LJ, and LeCluyse EL (2000) Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes. Xenobiotica 30:273-284.
39. Shimada T, Yamazaki H, Mimura M, Inui Y, and Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423.
40. Stresser DM and Kupfer D (1999) Monospecific antipeptide antibody to cytochrome P-450 2B6. Drug Metab Dispos 27:517-525.
41. Sueyoshi T, Kawamoto T, Zelko I, Honkakoski P, and Negishi M (1999) The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J Biol Chem 274:6043-6046.
42. Tzameli I, Pissios P, Schuetz EG, and Moore DD (2000) The xenobiotic compound 1, 4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. Mol Cell Biol 20:2951-2958.
43. Wang H, Faucette SR, Gilbert D, Jolley SL, Sueyoshi T, Negishi M, and LeCluyse EL (2003a) Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes. Drug Metab Dispos 31:620-630.
44. Wang H, Faucette S, Sueyoshi T, Moore R, Ferguson S, Negishi M, and LeCluyse EL (2003b) A novel distal enhancer module regulated by PXR/CAR is essential for the maximal induction of CYP2B6 gene expression. J Biol Chem 278:14146-14152.
45. Waxman DJ and Azaroff L (1992) Phenobarbital induction of cytochrome P-450 gene expression. Biochem J 281:577-592.
46. Xie W, Barwick JL, Simon CM, Pierce AM, Safe S, Blumberg B, Guzelian PS, and Evans RM (2000) Reciprocal activation of xenobiotic response genes by nuclear receptors SXR/PXR and CAR. Genes Dev 14:3014-3023.
47. Williams ML, Wainer IW, Embree L, Barnett M, Granvil CL, and Duchanne MP (1999) Enantio-selective induction of cyclophosphamide metabolism by phenytoin. Chirality 11:569-574.
48. Yanagihara Y, Kariya S, Ohtani M, Uchino K, Aoyama T, Yamamura Y, and Iga T (2001) Involvement of CYP2B6 in N-demethylation of ketamine in human liver microsomes. Drug Metab Dispos 29:887-890.
49. Zelko I and Negishi M (2000) Phenobarbital-elicited activation of nuclear receptor CAR in induction of cytochrome P450 genes. Biochem Biophys Res Commun 277:1-6.